WANBURY

Wanbury Share PriceWanbury

₹117.45
4.55 (4.03%)
As on 08 December, 2023 | 17:08 BSE: 524212 NSE: WANBURYISIN: INE107F01022

Wanbury Performance

Day Range

  • Low 117.45
  • High 117.45
₹ 117.45

52 Week Range

  • Low 33.30
  • High 117.45
₹ 117.45
  • Open Price0.00
  • Previous Close115.15
  • Volume3953

Start SIP in Wanbury

Start SIP

Wanbury Share Price

  • Over 1 Month 29.07%
  • Over 3 Month 85.99%
  • Over 6 Month 113.16%
  • Over 1 Year 133.04%

Wanbury Key Statistics

P/E Ratio 39.3
PEG Ratio -0.5
Market Cap Cr 385
Price to Book Ratio -11.7
EPS -3.1
Dividend 0
Relative Strength Index 89.1
Money Flow Index 89.94
MACD Signal 5.62
Average True Range 1.96

Wanbury Investment Rating

  • Master Rating:
  • Wanbury has an operating revenue of Rs. 549.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of -2% needs improvement, The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 30% and 96% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Wanbury Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 144146133126124117134
Operating Expenses Qtr Cr 127133119119118120122
Operating Profit Qtr Cr 17131466-313
Depreciation Qtr Cr 3333333
Interest Qtr Cr 8687435
Tax Qtr Cr 000000-1
Net Profit Qtr Cr 751-3-1-783
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 501513
Operating Expenses Annual Cr 476476
Operating Profit Annual in Cr 2335
Depreciation Cr 1211
Interest Annual Cr 2121
Tax Annual Cr 00
Net Profit Annual Cr -1081
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 41
Cash from Investing Activity Annual Cr 1
Cash from Financing Annual Activity Cr -29
Net Cash Flow Annual Cr 13
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr -72
Fixed Assets Annual Cr 153169
Total Non Current Assets Annual Cr 180179
Total Current Assets Annual Cr 123172
Total Assets Annual Cr 302351
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs -21
ROE Annual % 03,724
ROCE Annual % 129138
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 57
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 144146133126124117134
Operating Expenses Qtr Cr 127133119119118120122
Operating Profit Qtr Cr 17131466-313
Depreciation Qtr Cr 3333333
Interest Qtr Cr 8687435
Tax Qtr Cr 000000-1
Net Profit Qtr Cr 751-3-1-783
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 501513
Operating Expenses Annual Cr 476476
Operating Profit Annual in Cr 2335
Depreciation Cr 1211
Interest Annual Cr 2121
Tax Annual Cr 00
Net Profit Annual Cr -1081
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2041
Cash from Investing Activity Annual Cr -91
Cash from Financing Annual Activity Cr -32-29
Net Cash Flow Annual Cr -2113
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr -33-23
Fixed Assets Annual Cr 169169
Total Non Current Assets Annual Cr 180179
Total Current Assets Annual Cr 124173
Total Assets Annual Cr 304353
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs -10-7
ROE Annual % 0-348
ROCE Annual % -71-351
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 57

Wanbury Technicals

EMA & SMA

Current Price
₹117.45
4.55 (4.03%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹100.68
  • 50 Day
  • ₹89.29
  • 100 Day
  • ₹77.52
  • 200 Day
  • ₹67.52
  • 20 Day
  • ₹98.02
  • 50 Day
  • ₹88.43
  • 100 Day
  • ₹71.49
  • 200 Day
  • ₹58.47

Wanbury Resistance and Support

PIVOT
₹115.15
Resistance
First Resistance 115.15
Second Resistance 115.15
Third Resistance 115.15
RSI 89.10
MFI 89.94
MACD Single Line 5.62
MACD 7.06
Support
First Resistance 115.15
Second Resistance 115.15
Third Resistance 115.15

Wanbury Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 28,188 2,818,800 100
Week 87,097 8,709,740 100
1 Month 54,720 5,471,995 100
6 Month 47,637 4,763,711 100

Wanbury Result Highlights

Wanbury Synopsis

NSE-Medical-Generic Drugs

Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 499.65 Cr. and Equity Capital is Rs. 32.71 Cr. for the Year ended 31/03/2023. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.
Market Cap 385
Sales 549
Shares in Float 1.96
No of funds 4
Yield
Book Value 82.61
U/D Vol ratio 3.2
LTDebt / Equity
Alpha 0.33
Beta 0.74

Wanbury

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 39.8%39.84%39.84%39.84%
Mutual Funds
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 39.53%38.42%37.83%38.11%
Others 20.67%21.74%22.33%22.05%

Wanbury Management

Name Designation
Mr. K Chandran Vice Chairman & Whole Time Dir
Mr. N K Puri Ind. Non-Executive Director
Mr. S K Bhattacharya Ind. Non-Executive Director
Ms. Pallavi P Shedge Ind. Non-Executive Director
Mr. Binod Chandra Maharana Ind. Non-Executive Director
Dr. Manisha Juvekar Ind. Non-Executive Director

Wanbury Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Wanbury Corporate Action

Date Purpose Remarks
2023-10-20 Quarterly Results & Preferential issue Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company.
2023-08-11 Quarterly Results
2023-06-09 Audited Results (Revised)
2023-02-14 Quarterly Results
2022-11-28 Quarterly Results (Revised)

Wanbury FAQs

What is Share Price of Wanbury ?

Wanbury share price is ₹117 As on 08 December, 2023 | 16:54

What is the Market Cap of Wanbury ?

The Market Cap of Wanbury is ₹384.5 Cr As on 08 December, 2023 | 16:54

What is the P/E ratio of Wanbury ?

The P/E ratio of Wanbury is 39.3 As on 08 December, 2023 | 16:54

What is the PB ratio of Wanbury ?

The PB ratio of Wanbury is -11.7 As on 08 December, 2023 | 16:54

Q2FY23